Treatment-Driven • Partner-Focused • Community-Powered
Your donations have been driving and funding the CMTA’s Strategy to Accelerate Research – and our research is delivering results. Please donate now and help bring us one step closer to delivering safe and effective treatments to the 3 million people who are living with this disease.
Thanks to your continued support, the CMTA has become the leader in CMT research through our Strategy to Accelerate Research (STAR). We currently have over 25 active research projects with top labs around the world, tackling virtually all types of CMT. Each of these projects has been vetted through our STAR Advisory Board, which is comprised of 26 of the most preeminent CMT scientists from around the globe. We’ve also increased our research alliance network with pharmaceutical, biotechnology, and research service companies from two to 20 over a two-period.
We are determined to further accelerate our progress and gain more ground on all fronts. That’s why we are asking you to make your urgently needed year-end gift today so we can continue our fight against the progressive and devastating effects of CMT and ultimately put a stop to CMT.